Sam Hancock

M.Sci. Genetics

Sam completed his MSci in Genetics at the University of Nottingham in 2019, fuelled initially by an interest in genetic ageing. As part of his degree, he also investigated the role of rnh genes in originless replication in archaea.

Articles from Sam

Study suggests SARS-CoV-2 Omicron variant RBM binding may be weaker than in wild-type

A new study shows that the Omicron variant binds to the ACE2 receptor in a significantly weaker manner than other variants and the wild-type.

20 Dec 2021

Investigating SARS-CoV-2 genomics-informed outbreaks using new bioinformatics tools

Researchers have created a tool designed to make as much use of the overwhelming amount of SARS-CoV-2 data as possible.

17 Dec 2021

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Researchers from Westmead Hospital have been investigating the effect of a third dose on neutralizing antibody titres in already vaccinated individuals.

16 Dec 2021

Vaccine effectiveness of mRNA-1273 during the emergence of the SARS-CoV-2 Delta variant

The authors highlight that their research confirms the effectiveness of two doses of mRNA-1273 against SARS-CoV-2 infection.

16 Dec 2021

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Researches have been investigating the possibility of using convalescent plasma to help patients recover from COVID-19.

15 Dec 2021

Trajectory of SARS-CoV-2 vaccination and immunity examined in new model

Researchers have created a model of looking at the spread of COVID-19 that takes both vaccination rates and rates of loss of immunity into account and can be adjusted as factors change.

15 Dec 2021

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Researchers from the Duke Molecular Physiology Institute have been investigating genetic associations with more severe disease and examining the associations that certain genetic features have with other diseases.

13 Dec 2021

Cellular properties of SARS-CoV-2 spike protein RBD in virus-infected African green monkey kidney epithelial cells

Researchers from the Biological Defence Programme of Singapore have investigated six of these antibodies.

13 Dec 2021

SARS-CoV-2-specific T cell and antibody responses in healthcare workers that suffered from COVID-19 one year ago

Researchers have been investigating the immune response in previously infected healthcare workers after they receive these vaccines.

13 Dec 2021

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Researchers have screened several compounds that could show the ability to inhibit SARS-CoV-2.

10 Dec 2021

Sam Hancock

Articles from Sam

Study suggests SARS-CoV-2 Omicron variant RBM binding may be weaker than in wild-type

Investigating SARS-CoV-2 genomics-informed outbreaks using new bioinformatics tools

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Vaccine effectiveness of mRNA-1273 during the emergence of the SARS-CoV-2 Delta variant

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Trajectory of SARS-CoV-2 vaccination and immunity examined in new model

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Cellular properties of SARS-CoV-2 spike protein RBD in virus-infected African green monkey kidney epithelial cells

SARS-CoV-2-specific T cell and antibody responses in healthcare workers that suffered from COVID-19 one year ago

Screening FDA-approved compounds shown to possess antiviral or antimicrobial activity for SARS-CoV-2 inhibition

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News